Clinical Trial Award (Multiple Sclerosis Research Program, FY26)
Supports clinical trials advancing repair, neuroprotection, remyelination, or symptom management in multiple sclerosis under the Military Health System Research Program.
Funder: Military Health System Research Program
Due Dates (Anticipated): May 2026 (Letter of Intent) | June 2026 (Pre-application, eBRAP) | September 2026 (Full application, Grants.gov)
Funding Amounts: Up to $1,000,000 (3 years, Level 1) or $2,000,000 (4 years, Level 2) total costs per award.
Summary: Supports clinical trials to advance repair, neuroprotection, remyelination, or symptom management in multiple sclerosis.
Key Information: This is a forecasted opportunity; all dates and details are subject to change in the final announcement.
Description
The Clinical Trial Award under the Multiple Sclerosis Research Program (MSRP) is designed to accelerate the implementation of clinical trials addressing critical gaps in multiple sclerosis (MS) research. The award supports both small-scale, proof-of-principle studies and larger phase 1 or 2 trials that focus on repair, neuroprotection, remyelination, or symptom management in MS. Applicants must provide a strong scientific rationale, preliminary data, and propose clinical trials that address at least one of the program’s required focus areas. This mechanism is open to independent investigators at all career stages.
